Takashi Yokokawa

9PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biochemistry - carbohydrates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 19, 2026
Association between ABCB1 genetic polymorphisms with treatment outcomes in patients with metastatic pancreatic cancer.

|Aug 28, 2026
Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study.

|Jun 01, 2026
Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

|Nov 05, 2025
Early Higher Plasma Regorafenib Concentration Predicts Shorter PFS in Japanese Patients With mCRC.

Kazuo Kobayashi, Takeru Wakatsuki, Erika Sugiyama

|Nov 16, 2024
A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II).

Kenichi Suzuki, Takashi Yokokawa, Takashi Kawaguchi

|Apr 29, 2024
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study).

Masahiro Hatori, Daiki Tsuji, Kenichi Suzuki

Pageof 2

Frequent Collaborators

6 joint publications

Kazuyoshi Kawakami

6 joint publications

Daiki Tsuji

5 joint publications

Masahiro Hatori

4 joint publications

Kazuo Kobayashi